\n\n\n \n \n\n \n \n \n \n\n\n \n\n \n\n Oct 29, 2009 8:30 AM EDT
\n\n \n OXIS International Announces Successful Direct Mail Test for Ergoplex(TM), an Antioxidant Dietary Supplement - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Oct 21, 2009 8:30 AM EDT
\n\n \n OXIS International, Inc. Announces It Has Retained the Law Firm Quinn Emanuel Urquhart Oliver & Hedges, LLP - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Oct 21, 2009 2:59 AM EDT
\n\n \n OXIS International, Inc. Announces It Has Retained the Law Firm Quinn Emanuel Urquhart Oliver & Hedges, LLP - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Oct 12, 2009 8:30 AM EDT
\n\n \n OXIS International, Inc. Announces Sale of $2.0 Million in Convertible Debt - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Dec 04, 2007 12:01 AM EST
\n\n \n EQUITIES Magazine's Winter Discovery Day Conference XV to Host Dynamic Emerging Companies - GlobeNewswire\n \n \n | \n\n \n\n \n\n \n\n Apr 09, 2007 8:31 AM EDT
\n\n \n Alteon and OXIS International Expand Licensing Deal to Include Exclusive Rights of Organoselenium Compounds for All Indications - PR Newswire\n \n \n | \n\n \n\n \n\n \n\n Nov 13, 2006 8:33 AM EST
\n\n \n Alteon's ALT-2074 Demonstrates Ability to Reduce Infarct Size by 80 Percent in Mice with Haptoglobin 2-2 Genotype - PR Newswire\n \n \n | \n\n \n\n \n | \n
\n\n
\n\n");